Article

Genomic drivers of large B-cell lymphoma resistance to CD19 CAR-T therapy

medRxiv · 2021 · Jain, M. D.; Ziccheddu, B.; Coughlin, C. A.; Faramand, R.; Griswold, A. J.; Reid, K. M.; Landgren, O.; Locke, F. L.; Maura, F.; Davila, M. L.; Schatz, J. H.

Key facts

Title Genomic drivers of large B-cell lymphoma resistance to CD19 CAR-T therapy
First author Jain, M. D.; Ziccheddu, B.; Coughlin, C. A.; Faramand, R.; Griswold, A. J.; Reid, K. M.; Landgren, O.; Locke, F. L.; Maura, F.; Davila, M. L.; Schatz, J. H.
Journal medRxiv
Published Aug 26, 2021
DOI 10.1101/2021.08.25.457649
Devices mentioned K220060
Product codes mentioned MSJ, MVU, NGT, PFF, PFT

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature